dr. goy on the approval of pembrolizumab in pmbcl
Published 6 years ago • 214 plays • Length 1:35Download video MP4
Download video MP3
Similar videos
-
1:02
dr. goy on the progression of mcl treatment
-
1:04
dr. monk on the fda approval of pembrolizumab in cervical cancer
-
1:28
dr. goy on the evolution of treatment selection in mcl
-
1:27
dr. goy on the role of immunotherapy in mantle cell lymphoma
-
1:45
dr. goy comments on recent developments in the field of immunology
-
2:43
goy: pembrolizumab for hodgkin's lymphoma, multiple myeloma
-
1:36
dr. goy on immunotherapy in mantle cell lymphoma
-
1:15
dr. goy on treatment considerations in mcl
-
1:34
dr. goy on the evolution of treatment in mantle cell lymphoma
-
2:01
dr. goy on need for payment model for car t-cell therapy
-
1:35
dr. chu on the role of pembrolizumab in dmmr/msi-h mcrc
-
1:08
dr. goy on advancements in relapse/refractory mantle cell lymphoma
-
1:30
dr. goy on the role of mrd in mantle cell lymphoma
-
1:22
dr. goy on changing treatment landscape of mantle cell lymphoma
-
0:41
dr. goy on the potential utility of btk inhibitors as maintenance in mcl
-
1:11
dr. vose on acalabrutinib combination with pembrolizumab in dlbcl
-
1:07
dr. agarwala on impact of combining entinostat with pembrolizumab
-
1:35
dr. goy on prognostic markers in mantle cell lymphoma
-
1:06
dr. goy on efficacy with ibrutinib in mcl